Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-27T04:42:17.346Z Has data issue: false hasContentIssue false

The use of legal substances by persons with schizophrenia

Published online by Cambridge University Press:  16 April 2020

R.G. McCreadie
Affiliation:
Crichton Royal Hospital, Dumfries, United Kingdom
A. Dervaux
Affiliation:
Department of Substance Abuse, CH Sainte-Anne, Paris, France
J. de Leon
Affiliation:
UK MHRC Eastern State Hospital, Lexington, KY, USA
M. Gurpegui
Affiliation:
Department of Psychiatry and Institute of Neurosciences, University of Granada, Granada, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Poor diet habits and a more sedentary life may contribute to a worse physical health outcome of persons with schizophrenia, who are subjected to an increased risk of diabetes mellitus and other metabolic complications. These patients report greater euphoria and stimulatory effects in response to alcohol that may contribute to the increased risk for alcohol use disorders, which complicate the functional outcome of schizophrenia. Among subjects in this diagnostic group, those exposed to caffeine consumption tend to drink heavier amount of it, although the psychobiological implication of this finding has not been elucidated. Finally, there is worldwide a greater prevalence of tobacco smoking, heavy smoking and high nicotine dependence; and the available date support a theory of shared vulnerability to both smoking and schizophrenia rather than a self-medication hypothesis. The authors, all of whom have been contributors in this area, will discuss each other presentations

Type
W10. Workshop: The Use of Legal Substances by Persons with Schizophrenia
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.